| scholarly article | Q13442814 |
| P2093 | author name string | Xu Y | |
| Fisher DE | |||
| Wells AG | |||
| Dowland NR | |||
| Hemesath TJ | |||
| Hershey CL | |||
| Huber WE | |||
| Motyckova G | |||
| Takemoto CM | |||
| Weilbaecher KN | |||
| P2860 | cites work | The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 |
| MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes | Q59096765 | ||
| Roles of the Mitogen-activated Protein Kinase Family in Macrophage Responses to Colony Stimulating Factor-1 Addition and Withdrawal | Q61955153 | ||
| Pleiotropic effects of a null mutation in the c-fos proto-oncogene | Q62555352 | ||
| CBP/p300 as a co-factor for the Microphthalmia transcription factor | Q62746546 | ||
| Bone Resorption Restored in Osteopetrotic Mice by Transplants of Normal Bone Marrow and Spleen Cells | Q66903767 | ||
| Fusion disability of embryonic osteoclast precursor cells and macrophages in the microphthalmic osteopetrotic mouse | Q70104816 | ||
| Differential utilization of Trk autophosphorylation sites | Q71246045 | ||
| Bone metabolism in the osteopetrotic rat mutation microphthalmia blanc | Q72008194 | ||
| Neonatal reductions in osteoclast number and function account for the transient nature of osteopetrosis in the rat mutation microphthalmia blanc (mib) | Q72584937 | ||
| microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family | Q72801111 | ||
| A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro | Q77342999 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 | ||
| The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts | Q28140929 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9 | Q28145594 | ||
| TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif | Q28284930 | ||
| TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 | ||
| Enforced Expression of Bcl-2 in Monocytes Rescues Macrophages and Partially Reverses Osteopetrosis in op/op Mice | Q28593712 | ||
| Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice | Q29547898 | ||
| Cloning and characterization of the murine genes for bHLH-ZIP transcription factors TFEC and TFEB reveal a common gene organization for all MiT subfamily members | Q30558730 | ||
| mTFE3, an X-linked transcriptional activator containing basic helix-loop-helix and zipper domains, utilizes the zipper to stabilize both DNA binding and multimerization | Q33275913 | ||
| Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse | Q33646429 | ||
| Early events in M-CSF receptor signaling | Q33855769 | ||
| Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts | Q33939357 | ||
| Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family | Q34514934 | ||
| Requirement for NF-kappaB in osteoclast and B-cell development | Q35199657 | ||
| Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation | Q35745319 | ||
| Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors | Q35824058 | ||
| Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells | Q36230062 | ||
| Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. | Q36400364 | ||
| The c-fms gene complements the mitogenic defect in mast cells derived from mutant W mice but not mi (microphthalmia) mice. | Q37438572 | ||
| Structural organization of the human microphthalmia-associated transcription factor gene containing four alternative promoters. | Q40887733 | ||
| Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. | Q41121255 | ||
| Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse | Q41205540 | ||
| Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption | Q41772601 | ||
| Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse | Q43681246 | ||
| A Dominant Negative form of Transcription Activator mTFE3 Created by Differential Splicing | Q44409856 | ||
| Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein | Q44500763 | ||
| Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia | Q47860146 | ||
| Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. | Q50522916 | ||
| Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. | Q50522919 | ||
| The osteopetrotic syndrome in the microphthalmic mutant mouse. | Q53838306 | ||
| c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling | Q58326943 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 749-758 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Molecular Cell | Q3319468 |
| P1476 | title | Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice | |
| P478 | volume | 8 |
| Q36832193 | A RANKL-PKCβ-TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts |
| Q34561579 | Ablation of Tak1 in osteoclast progenitor leads to defects in skeletal growth and bone remodeling in mice |
| Q39676152 | Antiosteoporotic effects and proteomic characterization of the target and mechanism of an Er-Xian Decoction on osteoblastic UMR-106 and osteoclasts induced from RAW264.7. |
| Q33844646 | Baicalin positively regulates osteoclast function by activating MAPK/Mitf signalling |
| Q24300451 | Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability |
| Q93108880 | Bone Remodeling: Histone Modifications as Fate Determinants of Bone Cell Differentiation |
| Q33806257 | C-TAK1 interacts with microphthalmia-associated transcription factor, Mitf, but not the related family member Tfe3. |
| Q24675000 | Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation |
| Q35433533 | Deletion of histone deacetylase 7 in osteoclasts decreases bone mass in mice by interactions with MITF. |
| Q38923727 | Efficient delivery and functional expression of transfected modified mRNA in human embryonic stem cell-derived retinal pigmented epithelial cells |
| Q50689026 | Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β. |
| Q41842422 | Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors |
| Q24300916 | Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1 |
| Q90567724 | From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights |
| Q24683680 | Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner |
| Q34752049 | HDAC3 and HDAC7 have opposite effects on osteoclast differentiation |
| Q37833524 | Histochemistry and cell biology: the annual review 2010. |
| Q35848573 | Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation |
| Q39908266 | Impaired micro-RNA pathways diminish osteoclast differentiation and function |
| Q24324012 | Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization |
| Q29618116 | Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts |
| Q54775294 | Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells. |
| Q40586053 | Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes |
| Q90306391 | MITF and UV responses in skin: From pigmentation to addiction |
| Q36073894 | Mechanistic insight into osteoclast differentiation in osteoimmunology |
| Q37971335 | MicroRNAs and their roles in osteoclast differentiation |
| Q26752588 | MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis |
| Q35146535 | Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. |
| Q40756889 | Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling |
| Q34257775 | Mitf regulates osteoclastogenesis by modulating NFATc1 activity |
| Q36001179 | Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers |
| Q36830310 | Novel osteoclast signaling mechanisms. |
| Q34573852 | Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence |
| Q34872754 | Pigment pattern formation in zebrafish: a model for developmental genetics and the evolution of form |
| Q33715937 | Platelet and osteoclast β 3 integrins are critical for bone metastasis |
| Q38878942 | Proteomic approaches to study osteoclast biology |
| Q47256563 | RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1. |
| Q34611297 | Reaching a genetic and molecular understanding of skeletal development |
| Q33820660 | Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor |
| Q24562758 | Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains |
| Q28588438 | Renal carcinoma-associated transcription factors TFE3 and TFEB are leukemia inhibitory factor-responsive transcription activators of E-cadherin |
| Q57056148 | Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology |
| Q36082866 | Signaling networks that control the lineage commitment and differentiation of bone cells |
| Q33847268 | Subcellular localization of Mitf in monocytic cells |
| Q34312986 | Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner |
| Q28118825 | Sumoylation of MITF and its related family members TFE3 and TFEB |
| Q58710472 | Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder |
| Q40133607 | Targeted deletion of the osteoclast protein-tyrosine phosphatase (PTP-oc) promoter prevents RANKL-mediated osteoclastic differentiation of RAW264.7 cells. |
| Q42800802 | Tfe3 and Tfeb Transcriptionally Regulate Peroxisome Proliferator-Activated Receptor γ2 Expression in Adipocytes and Mediate Adiponectin and Glucose Levels in Mice |
| Q40219118 | Tfe3 expression is closely associated to macrophage terminal differentiation of human hematopoietic myeloid precursors. |
| Q35740987 | The 19S proteasomal lid subunit POH1 enhances the transcriptional activation by Mitf in osteoclasts |
| Q51810609 | The Importance of 11α-OH, 15-oxo, and 16-en Moieties of 11α-Hydroxy-15-oxo-kaur-16-en-19-oic Acid in Its Inhibitory Activity on Melanogenesis. |
| Q30009200 | The adaptor 3BP2 is required for KIT receptor expression and human mast cell survival |
| Q36716847 | The developmental biology of melanocytes and its application to understanding human congenital disorders of pigmentation |
| Q36078890 | The endocytic pathway in microglia during health, aging and Alzheimer's disease |
| Q35128232 | The genetic basis for skeletal diseases |
| Q52019222 | The microphthalmia-associated transcription factor requires SWI/SNF enzymes to activate melanocyte-specific genes. |
| Q37428651 | The multifunctional protein fused in sarcoma (FUS) is a coactivator of microphthalmia-associated transcription factor (MITF). |
| Q36994766 | The p85alpha subunit of class IA phosphatidylinositol 3-kinase regulates the expression of multiple genes involved in osteoclast maturation and migration |
| Q36819941 | The role played by key transcription factors in activated mast cells |
| Q50638779 | The transcription-repression domain of the adenovirus E1A oncoprotein targets p300 at the promoter. |
| Q28593951 | Transcription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunity |
| Q37322289 | Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis |
| Q46721602 | UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer |
| Q53172611 | Vitamin E decreases bone mass by stimulating osteoclast fusion. |
| Q28216002 | bcn-1 Element-dependent activation of the laminin gamma 1 chain gene by the cooperative action of transcription factor E3 (TFE3) and Smad proteins |
| Q39741079 | c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation |
| Q30496532 | miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate |
Search more.